INS and Hypoglycemia: After 1 yr, Eli Lilly introduced Iletin®, world's first commercially available insulin product for the treatment of diabetes; however, its drawbacks included short duration of action, multiple injections, high risk of hypoglycaemia, and allergic reactions.